• OPEN AN ACCOUNT
Indian Indices
Nifty
25,044.35 72.45
(0.29%)
Sensex
82,800.81 745.70
( 0.91%)
Bank Nifty
56,461.90 402.55
( 0.72%)
Nifty IT
38,417.95 3.85
( 0.01%)
Global Indices
Nasdaq
43,117.37 514.58
(1.21%)
Dow Jones
6,114.62 68.45
(1.13%)
Hang Seng
38,915.23 124.67
(0.32%)
Nikkei 225
8,758.99 0.95
(0.01%)
Forex
USD-INR
86.62 0.13
(0.15%)
EUR-INR
99.78 0.17
(0.17%)
GBP-INR
116.55 0.28
(0.24%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Pharmaids Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524572
INE117D01018
18.0866939
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
203.88
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Lactose (India) Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 30Th May 2025
May 30,2025
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform that the Board of Directors of the Company at their meeting held on Friday 30th May 2025 has inter alia considered and approved the followings items of agenda: 1. Audited Financial Results along with Auditors Report for the Fourth quarter and Financial year ended 31st March 2025; Pursuant to Regulation 33(3)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended. We do hereby confirm that the Statutory auditors of the Company M/s. DMKH & Co. have expressed unmodified opinion(s) in its audit report pertaining to the audited financial results for the quarter and year ended 31st March 2025. The Meeting of the Board of Directors of the Company was commenced at 12.30 P.M. and concluded at 01.40 P.M.